Skip to content
Picture of the article on genomics and la génomique et la maladie des petits vaisseaux cérébraux
Picture generated with the help of artificial intelligence

Cerebral small vessel disease (cSVD) is a leading cause of stroke and dementia. Genetic risk loci for white matter hyperintensities (WMH), the most common MRI-marker of cSVD in older age, were recently shown to be significantly associated with white matter (WM) microstructure on diffusion tensor imaging (signal-based) in young adults. To provide new insights into these early changes in WM microstructure and their relation with cSVD, the researchers sought to explore the genetic underpinnings of cutting-edge tissue-based diffusion imaging markers across the adult lifespan.

Design and measures

In this study, the researchers conducted a genome-wide association study of neurite orientation dispersion and density imaging (NODDI) markers in young adults (i-Share study: N = 1 758, (mean[range]) 22.1[18–35] years), with follow-up in young middle-aged (Rhineland Study: N = 714, 35.2[30–40] years) and late middle-aged to older individuals (UK Biobank: N = 33 224, 64.3[45–82] years).

They identified 21 loci associated with NODDI markers across brain regions in young adults. The most robust association, replicated in both follow-up cohorts, was with Neurite Density Index (NDI) at chr5q14.3, a known WMH locus in VCAN.

Two additional loci were replicated in UK Biobank, at chr17q21.2 with NDI, and chr19q13.12 with Orientation Dispersion Index (ODI). Transcriptome-wide association studies showed associations of STAT3 expression in arterial and adipose tissue (chr17q21.2) with NDI, and of several genes at chr19q13.12 with ODI.

Genetic susceptibility to larger WMH volume, but not to vascular risk factors, was significantly associated with decreased NDI in young adults, especially in regions known to harbor WMH in older age.

Individually, seven of 25 known WMH risk loci were associated with NDI in young adults.

Results

Multiple novel genetic risk loci associated with NODDI markers were identified, particularly NDI, in early adulthood. These point to possible early-life mechanisms underlying cSVD and to processes involving remyelination, neurodevelopment and neurodegeneration, with a potential for novel approaches to prevention.

Scientific publication

Le Grand, Q., Tsuchida, A., Koch, A. et al. Diffusion imaging genomics provides novel insight into early mechanisms of cerebral small vessel disease. Mol Psychiatry (2024). https://doi.org/10.1038/s41380-024-02604-7

More news

Awards - Research
Picture of the article on the SPARK Bordeaux 2024 program

Our researcher Claire Peghaire is a winner of the SPARK Bordeaux 2024 program! Find out more about her research project.

Research
Picture of the article on proteogenomics in cerebrospinal fluid and plasma

Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel disease.

How can you support the Institute?

Your help is essential in the fight against stroke and dementia, and for the promotion of healthy brain ageing.

By supporting cutting-edge research to develop new prevention strategies and personalised therapies for vascular brain diseases, you are helping reduce the burden of these diseases worldwide.

Your donation entitles you to a tax reduction.
E.g.: If I am taxable and I donate €50, my donation will only cost me €12 after tax reduction.

Back To Top